Tech Support

TECHNICAL SUPPORT
+1.800.674.3430

This line is for technical support.
For General Enquiries please click General Contact

SYMPOSIUM - CrownBio's Inaugural NASH Summit

Shanghai, China, August 28, 2019 - Parkyard Hotel

Shanghai, China, Parkyard HotelWe're delighted to invite you to our inaugural NASH Summit, focusing on the trends and translational models across NASH drug discovery and development.

As the first therapy for nonalcoholic steatohepatitis (NASH) closes in on approval, further single agent and combination therapy development is extensively ongoing. To improve this development, enhanced preclinical models are needed which better replicate all aspects of human NASH, and improve translation of novel agents to the clinic.

The symposium will bring together NASH R&D and preclinical teams from pharmaceutical and biotech companies to facilitate cross discipline discussions on current techniques, and how to move forward with future approaches.

Discussion Topics Include

  • How to apply translational NASH models to enhance preclinical development programs
  • Current trends and future opportunities in NASH drug discovery and development
  • The progress of NASH research in China

Presentation & Speakers

Dr. Yixin (Jim) Wang

SVP Cardiovascular and Metabolic Disease Research, Crown Bioscience
Translational animal models of NASH: from rodents to nonhuman primates

Yongqiang Shan MD/PhD

Head & Director of Discovery Biology, HuaMedicine(Shanghai) Ltd.
Some critical considerations for NASH drug discovery

Dr. Xiaoxin Chen

Board/VP, Guangdong Zhongsheng Pharmaceutical Co., Ltd.
The novel opportunities of NASH research in China

Dr. Zhouzhou

Director of Pharmacology & Scientific Affairs, Terns Pharmaceuticals, Inc.
Trends in NASH drug development

Haiqing Gu

JAX Regional Development Liaison, China
JAX mice and services in China

Attendance is free, but seats are limited, reserve your space by submitting the registration form today!

Reserve Your Seat Now!

Register Now

Your privacy is important to us.
We'll never share your information.

SHARE THIS